Italian Medicines Agency Agenzia Italiana del Farmaco

AIFA: precautionary suspension of the AstraZeneca vaccine - AIFA: precautionary suspension of the AstraZeneca vaccine

Asset Publisher

AIFA: precautionary suspension of the AstraZeneca vaccine

AIFA has decided to extend the ban on the use of the AstraZeneca Covid19 vaccine throughout the country as a precaution and temporarily, pending the rulings of the EMA. This decision was taken in line with similar measures adopted by other European countries.

Further investigations are currently underway. AIFA, in coordination with EMA and other European countries, will jointly evaluate all the events that have been reported following the vaccination.


Published on: 15 March 2021

Asset Publisher

Related documents

Asset Publisher

Galleria

Nested Applications

Last tweets

Go to Twitter profile

Multimedia

ABC della Ricerca Clinica - Perché la randomizzazione è essenziale?

Go to YouTube channel

go to beginning of content